LIEN vs IRD
Comparison between Chicago Atlantic BDC Inc (LIEN, Company) and Ocuphire Pharma Inc (IRD, Company).
LIEN is from the Financial Services sector, while IRD is from the Healthcare sector.
LIEN vs IRD - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
LIEN vs IRD - Historical Returns
Returns include dividend reinvestment.
LIEN vs IRD - Annual Returns (2005 - 2026)
Returns include dividend reinvestment.
| Year | LIEN | IRD |
|---|---|---|
| 2026 | -2.65% | +45.28% |
| 2025 | -6.78% | +59.52% |
| 2024 | +58.26% | -61.24% |
| 2023 | +2.77% | -14.25% |
| 2022 | -30.00% | -12.84% |
| 2021 | N/A | -46.71% |
| 2020 | N/A | -19.28% |
| 2019 | N/A | -83.42% |
| 2018 | N/A | -55.71% |
| 2017 | N/A | +39.21% |
| 2016 | N/A | -58.34% |
| 2015 | N/A | -50.50% |
| 2014 | N/A | +36.13% |
| 2013 | N/A | +59.67% |
| 2012 | N/A | -22.50% |
| 2011 | N/A | -66.73% |
| 2010 | N/A | +69.70% |
| 2009 | N/A | -20.00% |
| 2008 | N/A | -60.44% |
| 2007 | N/A | +66.59% |
| 2006 | N/A | -32.50% |
| 2005 | N/A | -33.33% |
LIEN vs IRD Drawdown Comparison
The maximum drawdown for LIEN was -46.91%, occurring on Jul 25, 2023. Recovery took 570 trading sessions.
The maximum drawdown for IRD was -99.98%, occurring on Apr 11, 2025. This drawdown has not yet recovered.
The current LIEN drawdown is -11.35%. The current IRD drawdown is -99.89%.
| Rank | LIEN | IRD |
|---|---|---|
| #1 | -46.91% Mar 11, 2022 - Jun 18, 2024 | -99.98% May 27, 2008 - Apr 11, 2025 |
| #2 | -22.38% Oct 15, 2024 - Jun 20, 2025 | -78.00% Aug 29, 2006 - May 27, 2008 |
| #3 | -10.31% Jun 18, 2024 - Oct 4, 2024 | -75.00% Aug 25, 2005 - Aug 29, 2006 |
| #4 | -4.64% Feb 11, 2022 - Mar 11, 2022 | -23.08% Jun 22, 2005 - Jul 27, 2005 |
| #5 | -0.70% Oct 10, 2024 - Oct 14, 2024 | -16.67% May 23, 2005 - Jun 22, 2005 |
| #6 | -0.25% Feb 4, 2022 - Feb 10, 2022 | N/A |
Correlation
Correlation between LIEN and IRD is -0.46 which considered as a weak negative correlation - the stocks show a slight tendency to move in opposite directions.
Select Stocks to Compare
More Comparisons
Compare with similar stocks